1. Successful integration of the MACSQuant® Analyzer in high-throughput research
2. Enabling characterization of genetically modified T cells used for immunotherapy
Room: Hörsaal H (Speaker Room H)
1. Dr. Julian Braun, Postdoc / Wissenschaftlicher Mitarbeiter, BIH Center for Regenerative Therapies BCRT Charité – Universitätsmedizin Berlin
2. Dr. Sonja Schallenberg, Team Coordinator R&D Immunotherapy, Miltenyi Biotec B.V. & Co. KG
Maximize efficiency while enjoying the certainty – MACS® Quant Analyzers; Lunch symposium with Miltenyi Biotec ; Join us as we hear from experts in the field about the integration and application of the MACS® Quant Analyzer in their respective research over a free lunch! Hear from Dr. Julian Braun as he describes how his team at AG Thiel have utilized the MACS® Quant Analyzer in multiple studies to generate huge datasets related to assessing T cell reactivity towards the COVID-19 pathogen. They have identified pre-existing, cross-reactive immunity in naïve donors and decided to dive deeper into monitoring infection- and vaccination-induced immunity with a workforce of five MACSQuant instruments. Additionally, Dr. Sonja Schallenberg will share her team’s research in enabling flow cytometry-based characterization of genetically modified T cells and the challenges of cell composition, phenotype, or activation state measurement of chimeric antigen receptor (CAR) T cells they have overcome with the MACS® Quant Analyzer. We are looking forward to these fascinating talks, and can’t wait to see you there!